Global Intravenous (IV) Iron Drugs Market Research Report 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 93

Report ID: 11103

Iron infusion is a procedure in which iron is delivered to your body intravenously, meaning into a vein through a needle. This method of delivering medication or supplementation is also known as an intravenous (IV) infusion. Iron infusions are usually prescribed by doctors to treat iron deficiency anemia.
Iron is one of the most important mineral present inside the human body. It carries oxygen throughout the body via the blood, which is further utilized by cells and tissue to get energy for all vital biological processes. Moreover, deficiency of iron leads to severe health problems, such as anemia and also affects mental or other memory functions in youths. To overcome this problem, oral iron supplements are recommended to maintain the iron level in the body. However, in some cases, oral administrations are not capable of maintaining the iron level in the body. For these cases, IV iron therapy is used to as part of which iron is directly injected inside the body with a needle through a vein.

The global Intravenous (IV) Iron Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Intravenous (IV) Iron Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Intravenous (IV) Iron Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Sanofi
Allergan
AMAG Pharmaceuticals
Dalichi Sankyo
Luitpold Pharmaceuticals
Pharmacosmos
Takeda Pharmaceutical
...

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Ferric Carboxymaltose
Iron Sucrose
Iron Dextran
Others

Segment by Application
Nephrology
Gynecology & Obstetrics
Gastroenterology
Oncology
Cardiology
Others

Table of Contents

Executive Summary
1 Intravenous (IV) Iron Drugs Market Overview
1.1 Product Overview and Scope of Intravenous (IV) Iron Drugs
1.2 Intravenous (IV) Iron Drugs Segment by Type
1.2.1 Global Intravenous (IV) Iron Drugs Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Ferric Carboxymaltose
1.2.3 Iron Sucrose
1.2.4 Iron Dextran
1.2.5 Others
1.3 Intravenous (IV) Iron Drugs Segment by Application
1.3.1 Intravenous (IV) Iron Drugs Consumption Comparison by Application (2014-2025)
1.3.2 Nephrology
1.3.3 Gynecology & Obstetrics
1.3.4 Gastroenterology
1.3.5 Oncology
1.3.6 Cardiology
1.3.7 Others
1.4 Global Intravenous (IV) Iron Drugs Market by Region
1.4.1 Global Intravenous (IV) Iron Drugs Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Intravenous (IV) Iron Drugs Market Size
1.5.1 Global Intravenous (IV) Iron Drugs Revenue (2014-2025)
1.5.2 Global Intravenous (IV) Iron Drugs Production (2014-2025)

2 Global Intravenous (IV) Iron Drugs Market Competition by Manufacturers
2.1 Global Intravenous (IV) Iron Drugs Production Market Share by Manufacturers (2014-2019)
2.2 Global Intravenous (IV) Iron Drugs Revenue Share by Manufacturers (2014-2019)
2.3 Global Intravenous (IV) Iron Drugs Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Intravenous (IV) Iron Drugs Production Sites, Area Served, Product Types
2.5 Intravenous (IV) Iron Drugs Market Competitive Situation and Trends
2.5.1 Intravenous (IV) Iron Drugs Market Concentration Rate
2.5.2 Intravenous (IV) Iron Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Intravenous (IV) Iron Drugs Production Market Share by Regions
3.1 Global Intravenous (IV) Iron Drugs Production Market Share by Regions
3.2 Global Intravenous (IV) Iron Drugs Revenue Market Share by Regions (2014-2019)
3.3 Global Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Intravenous (IV) Iron Drugs Production
3.4.1 North America Intravenous (IV) Iron Drugs Production Growth Rate (2014-2019)
3.4.2 North America Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Intravenous (IV) Iron Drugs Production
3.5.1 Europe Intravenous (IV) Iron Drugs Production Growth Rate (2014-2019)
3.5.2 Europe Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Intravenous (IV) Iron Drugs Production (2014-2019)
3.6.1 China Intravenous (IV) Iron Drugs Production Growth Rate (2014-2019)
3.6.2 China Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Intravenous (IV) Iron Drugs Production (2014-2019)
3.7.1 Japan Intravenous (IV) Iron Drugs Production Growth Rate (2014-2019)
3.7.2 Japan Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Intravenous (IV) Iron Drugs Consumption by Regions
4.1 Global Intravenous (IV) Iron Drugs Consumption by Regions
4.2 North America Intravenous (IV) Iron Drugs Consumption (2014-2019)
4.3 Europe Intravenous (IV) Iron Drugs Consumption (2014-2019)
4.4 China Intravenous (IV) Iron Drugs Consumption (2014-2019)
4.5 Japan Intravenous (IV) Iron Drugs Consumption (2014-2019)

5 Global Intravenous (IV) Iron Drugs Production, Revenue, Price Trend by Type
5.1 Global Intravenous (IV) Iron Drugs Production Market Share by Type (2014-2019)
5.2 Global Intravenous (IV) Iron Drugs Revenue Market Share by Type (2014-2019)
5.3 Global Intravenous (IV) Iron Drugs Price by Type (2014-2019)
5.4 Global Intravenous (IV) Iron Drugs Production Growth by Type (2014-2019)

6 Global Intravenous (IV) Iron Drugs Market Analysis by Applications
6.1 Global Intravenous (IV) Iron Drugs Consumption Market Share by Application (2014-2019)
6.2 Global Intravenous (IV) Iron Drugs Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Intravenous (IV) Iron Drugs Business
7.1 Sanofi
7.1.1 Sanofi Intravenous (IV) Iron Drugs Production Sites and Area Served
7.1.2 Intravenous (IV) Iron Drugs Product Introduction, Application and Specification
7.1.3 Sanofi Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Allergan
7.2.1 Allergan Intravenous (IV) Iron Drugs Production Sites and Area Served
7.2.2 Intravenous (IV) Iron Drugs Product Introduction, Application and Specification
7.2.3 Allergan Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 AMAG Pharmaceuticals
7.3.1 AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Production Sites and Area Served
7.3.2 Intravenous (IV) Iron Drugs Product Introduction, Application and Specification
7.3.3 AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Dalichi Sankyo
7.4.1 Dalichi Sankyo Intravenous (IV) Iron Drugs Production Sites and Area Served
7.4.2 Intravenous (IV) Iron Drugs Product Introduction, Application and Specification
7.4.3 Dalichi Sankyo Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Luitpold Pharmaceuticals
7.5.1 Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Production Sites and Area Served
7.5.2 Intravenous (IV) Iron Drugs Product Introduction, Application and Specification
7.5.3 Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Pharmacosmos
7.6.1 Pharmacosmos Intravenous (IV) Iron Drugs Production Sites and Area Served
7.6.2 Intravenous (IV) Iron Drugs Product Introduction, Application and Specification
7.6.3 Pharmacosmos Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Takeda Pharmaceutical
7.7.1 Takeda Pharmaceutical Intravenous (IV) Iron Drugs Production Sites and Area Served
7.7.2 Intravenous (IV) Iron Drugs Product Introduction, Application and Specification
7.7.3 Takeda Pharmaceutical Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served

8 Intravenous (IV) Iron Drugs Manufacturing Cost Analysis
8.1 Intravenous (IV) Iron Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Intravenous (IV) Iron Drugs
8.4 Intravenous (IV) Iron Drugs Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Intravenous (IV) Iron Drugs Distributors List
9.3 Intravenous (IV) Iron Drugs Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Intravenous (IV) Iron Drugs Market Forecast
11.1 Global Intravenous (IV) Iron Drugs Production, Revenue Forecast
11.1.1 Global Intravenous (IV) Iron Drugs Production Growth Rate Forecast (2019-2025)
11.1.2 Global Intravenous (IV) Iron Drugs Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Intravenous (IV) Iron Drugs Price and Trend Forecast (2019-2025)
11.2 Global Intravenous (IV) Iron Drugs Production Forecast by Regions (2019-2025)
11.2.1 North America Intravenous (IV) Iron Drugs Production, Revenue Forecast (2019-2025)
11.2.2 Europe Intravenous (IV) Iron Drugs Production, Revenue Forecast (2019-2025)
11.2.3 China Intravenous (IV) Iron Drugs Production, Revenue Forecast (2019-2025)
11.2.4 Japan Intravenous (IV) Iron Drugs Production, Revenue Forecast (2019-2025)
11.3 Global Intravenous (IV) Iron Drugs Consumption Forecast by Regions (2019-2025)
11.3.1 North America Intravenous (IV) Iron Drugs Consumption Forecast (2019-2025)
11.3.2 Europe Intravenous (IV) Iron Drugs Consumption Forecast (2019-2025)
11.3.3 China Intravenous (IV) Iron Drugs Consumption Forecast (2019-2025)
11.3.4 Japan Intravenous (IV) Iron Drugs Consumption Forecast (2019-2025)
11.4 Global Intravenous (IV) Iron Drugs Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Intravenous (IV) Iron Drugs Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer